Suffice it to say, it has been a banner week in the world of stem cells. In this rapidly-changing market environment, it can be difficult to keep up with current events. To help you out, we’ve released new content on stem cell markets that we are excited to share with you. Let me know what you think! [Read more…]
Pluristem Fortifies IP Position and Partnering Potential in Japan with Two Key Cell Therapy Patents
In major news released today, Pluristem Therapeutics announced that it had been granted two key cell therapy patents in Japan. Pluristem Therapeutics is a clinical-stage biotechnology company that uses placental cells and a proprietary, three-dimensional technology platform to develop cell therapies for a broad range of diseases.
Therefore, the patents pertain to the three-dimensional growth of placental and fat cells and the use of placental cells grown with 3D technology:
- Patent No. 5733894, titled “Methods for Cell Expansion and Uses of Cells and Conditioned Media Produced Thereby for Therapy
- Patent No. 5766041, titled “Pharmaceutical Composition for Enhancing Subject Hematopoietic System”
To learn more about the company, see our recent interview Dr. Racheli Ofir, VP Research & Intellectual Property for Pluristem Therapeutics. Or, read the full press release below, printed with permission from Dr. Ofir. [Read more…]
European Bank for iPS Cells Launches Cells for Disease Modelling and Preclinical Research
Recently the European Bank for induced pluripotent Stem Cells (EBiSC) announced the launch of its on-line catalogue of iPSCs for use in disease modeling and pre-clinical research. The cell lines were created and deposited by EBiSC partner labs and a broad range of external organisations.
Upcoming efforts will introduce to the bank a large number of Parkinson’s and Alzheimer’s Disease lines, as well as lines for diabetes, cardiovascular research, muscular dystrophies, neuropathic pain, and more. These new lines will be produced through external collaborations, as well as cell line creation within the EBiSC.
Specifically, EBiSC announced: [Read more…]
6 Reasons Your Survival Depends on Stem Cell Market Intelligence
The first and only market research firm to specialize in the stem cell industry, BioInformant has more than a decade of historical information on all segments of the stem cell market.
The following are six more reasons that your survival depends on stem cell market intelligence. [Read more…]
Do You Know What Regions are Doing the Most Searches for Mesenchymal Stem Cells (MSCs)?
Google Trends is a supplemental service of Google Incorporated that analyzes trend data collected through Google Search.
It shows how often a particular search term is entered relative to total search-volume across various regions of the world and in various languages.
It is an absolutely incredible market research tool for assessing stem cell market dynamics, because it reflects real-time social behavior related to specific stem cell types and provides public access to Google’s online search information. [Read more…]
- « Previous Page
- 1
- …
- 167
- 168
- 169
- 170
- 171
- …
- 201
- Next Page »